Study Complete
Sponsor ID
20060119

Long-Term Assessment of Safety and Physical Function with AMG 108 in RA

Sponsor ID
20060119
Clinicaltrials.gov ID
NCT00369473
EUCTIS ID
N/A
EudraCT ID
N/A

Study Details

The purpose of this study is to assess long-term safety of SC AMG 108 in the treatment of RA

Additional Study Details

Phase
Phase 2
Product
AMG 108
Type
Interventional
Masking
Triple (Participant, Investigator, Outcomes Assessor)
Enrollment
690
Additional Study Details

Protocol Summary

Primary Outcome Measures

To assess long-term safety of AMG 108 SC in subjects with RA previously enrolled in study 20050168

Timeframe: 144 Weeks

Secondary Outcome Measures

To determine whether long-term use of AMG 108 improves function in subjects with RA

Timeframe: 144 Weeks

Study Documents

Study Synopsis
Available Language(s): English

Locations

No locations found.